These clowns would need to dilute for another couple years at there prices to have any chance at trials. Bringing a drug, which they dont have, nor will ever have, taken hundreds of millions. They couldnt afford to pay lonza 687,000 for a batch. That's just for a batch.
Except the same narrative/PRs as years past.....cant get financing, setup a new agreement with another manufacturer, submitted health Canada DEL/DIN paperwork, extended agreement with McGill....all those things take $$$$. That's all this recent dilution can afford to do. Carry on the same BS narrative. This will slip back to trips, then they will start the cant get funding our stock has no value, we are worth a billion dollars, but we cant trade over a penny, we have no income, or workers......we cant even qualify for the dreaded S-1 funding scheme.
No one is running this thing. Based on that alone, they will never get funding. The heavy dilution will also be used to pay their unjustified salaries, pay their personal companies linked to SBFM/funnel money...we have seen the filings....or funneled to their personal companies for services rendered, despite have no proof.
Or to pay/extend the notes.....theres plenty. Just read the filings.
Expect no movement here, more dilution, and trips. They want this stock to move to a point it even qualifies for predatory lending, announce new directors. Not vegan approval for someone elses random supplements.
ALL IMO.
